CLINICAL_TRIALS
trial_result
· 2024-09-25
Clinical Trial Update: Hidradenitis Suppurativa Phase 2b Study of Izokibep [Phase 2]
Summary
ACELYRIN Inc. announced that a Phase 2b trial of izokibep for hidradenitis suppurativa has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ACELYRIN Inc. | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2024-09-25